http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000035794-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
filingDate 1997-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa1d255b18e03f81af541ef85793cec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce90784b64c9b58af217f3e49eaa0ac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74e2ef73e0bb77fcfe96a310bc7bc3e0
publicationDate 2000-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20000035794-A
titleOfInvention Synthesis of cisapride
abstract The present invention is directed to reductive amination of 1- [3- (4-fluorophenoxy) -propyl] -3-methoxy-4-piperidinone under hydrogen in a suitable reaction-inert solvent in the presence of benzylamine. Obtain 1- [3- (4-fluorophenoxy) -propyl] -3-methoxy-4-piperidinamine having a cis / trans ratio of about 93/7, and the obtained compound is a suitable inorganic acid in a suitable solvent. And converted to its acid addition salt and crystallized, and then converted to its free base by treatment with an appropriate base to give 1- [3- (4-fluorophenoxy) -propyl]-with a cis / trans ratio of at least 98/2. The amount of cis-stereoisomers is increased by obtaining 3-methoxy-4-piperidinamine, followed by cis-1- [3- (4-fluorophenoxy) -propyl] -3-methoxy 4-piperidinamine is reacted with ethyl chloroformate and 4-amino-5-chloro-2-methoxy-benzoic acid in a reaction-inert solvent And the characterized in that the obtained relates to a novel process for preparing acid addition salts and pharmaceutically acceptable cisapride.
priorityDate 1996-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419832797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13677832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415773513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447869273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447586071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449422410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11065870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419832794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86676953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17870801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447852929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430824729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21912024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22005578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504

Total number of triples: 49.